Adrian Adams
2021 - IMPEL PHARMACEUTICALS
In 2021, Adrian Adams earned a total compensation of $2.4M as Chief Executive Officer and President at IMPEL PHARMACEUTICALS, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $431,250 |
|---|---|
| Option Awards | $529,300 |
| Salary | $525,172 |
| Stock Awards | $933,000 |
| Total | $2,418,722 |
Adams received $933K in stock awards, accounting for 39% of the total pay in 2021.
Adams also received $431.3K in non-equity incentive plan, $529.3K in option awards and $525.2K in salary.
Rankings
In 2021, Adrian Adams' compensation ranked 5,282nd out of 12,397 executives tracked by ExecPay. In other words, Adams earned more than 57.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,282 out of 12,397 | 57th |
Division Manufacturing | 2,222 out of 5,492 | 60th |
Major group Chemicals And Allied Products | 967 out of 2,367 | 59th |
Industry group Drugs | 861 out of 2,090 | 59th |
Industry Pharmaceutical Preparations | 619 out of 1,537 | 60th |
Source: SEC filing on April 26, 2022.
Adams' colleagues
We found two more compensation records of executives who worked with Adrian Adams at IMPEL PHARMACEUTICALS in 2021.